Development of 225Ac- and 213Bi-labelled somatostatin analogues with improved tumour to kidney ratio for the treatment of neuroendocrine tumours
| Universiteit | KU LEUVEN |
|---|---|
| Opleiding gestart op | |
| Thesis behaald op |
Mentor
Ooms MaartenPromotor
Bormans GuyKandidaat
Ahenkorah StephenBefore applying, please consult the guidelines for application for PhD